COX-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation

British Journal of Pharmacology

Volumn 164, Issue 6, 2011, Pages 1672-1683

  Straiker, A ^a,b   Wager Miller, J ^a   Hu, S S ^a   Blankman, J L ^c   Cravatt, B F ^c   MacKie, K ^a  

^a INDIANA UNIVERSITY   (United States)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

2 AG; ABHD12; ABHD6; COX 2; DSE; endocannabinoid; retrograde transmission

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ACYLGLYCEROL LIPASE; ALPHA BETA HYDROLASE DOMAIN 12; ALPHA BETA HYDROLASE DOMAIN 6; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; CYCLOOXYGENASE 2; ENDOCANNABINOID; FATTY ACID AMIDASE; HYDROLASE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DEPOLARIZATION; DEPOLARIZATION INDUCED SUPPRESSION OF EXCITATION; DEPOLARIZATION INDUCED SUPPRESSION OF INHIBITION; ELECTROENCEPHALOGRAM; ENZYME REGULATION; GENE DELETION; HIPPOCAMPUS; MOUSE; NERVE CELL PLASTICITY; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION;

AMIDOHYDROLASES; ANIMALS; CELLS, CULTURED; CYCLOOXYGENASE 2; HIPPOCAMPUS; MICE; MICE, KNOCKOUT; MONOACYLGLYCEROL LIPASES; NEURONS; SYNAPTIC TRANSMISSION;

EID: 80052976382     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01486.x     Document Type: Article

References (60)

1. Adams J, Collaco-Moraes Y, de Belleroche J, (1996). Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitation. J Neurochem 66: 6-13. (Pubitemid 26010758)
2. Alexander SPH, Mathie A, Peters JA, (2009). Guide to Receptors and Channels (GRAC). Br J Pharmacol 158 (Suppl. 1): 254.
3. Bekkers JM, Stevens CF, (1991). Excitatory and inhibitory autaptic currents in isolated hippocampal neurons maintained in cell culture. Proc Natl Acad Sci USA 88: 7834-7838. (Pubitemid 21915249)
4. Blankman JL, Simon GM, Cravatt BF, (2007). A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol 14: 1347-1356. (Pubitemid 350257008)
5. Bodor AL, Katona I, Nyiri G, Mackie K, Ledent C, Hajos N, et al,. (2005). Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci 25: 6845-6856. (Pubitemid 41023152)
6. Bracey MH, Hanson MA, Masuda KR, Stevens RC, Cravatt BF, (2002). Structural adaptations in a membrane enzyme that terminates endocannabinoid signaling. Science 298: 1793-1796. (Pubitemid 35404124)
7. Burian M, Geisslinger G, (2005). COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites. Pharmacol Ther 107: 139-154. (Pubitemid 40910038)
8. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB, (1996). Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384: 83-87. (Pubitemid 26374593)
9. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, et al,. (2001). Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 98: 9371-9376. (Pubitemid 32743923)
10. Dantzer R, Bluthe RM, Gheusi G, Cremona S, Laye S, Parnet P, et al,. (1998). Molecular basis of sickness behavior. Ann NY Acad Sci 856: 132-138. (Pubitemid 28517345)
11. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al,. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949. (Pubitemid 23026736)
12. Di Marzo V, Bisogno T, Sugiura T, Melck D, De Petrocellis L, (1998). The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide. Biochem J 331 (Pt 1): 15-19. (Pubitemid 28163951)
13. Di S, Boudaba C, Popescu IR, Weng FJ, Harris C, Marcheselli VL, et al,. (2005). Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. J Physiol 569: 751-760. (Pubitemid 41830220)
14. Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, et al,. (2002). Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 99: 10819-10824.
15. Egertova M, Giang DK, Cravatt BF, Elphick MR, (1998). A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain. Proc R Soc Lond B Biol Sci 265: 2081-2085. (Pubitemid 28502544)
16. Fiskerstrand T, H'Mida-Ben Brahim D, Johansson S, M'Zahem A, Haukanes BI, Drouot N, et al,. (2010). Mutations in ABHD12 cause the neurodegenerative disease PHARC: an inborn error of endocannabinoid metabolism. Am J Hum Genet 87: 410-417.
17. Furshpan EJ, MacLeish PR, O'Lague PH, Potter DD, (1976). Chemical transmission between rat sympathetic neurons and cardiac myocytes developing in microcultures: evidence for cholinergic, adrenergic, and dual-function neurons. Proc Natl Acad Sci USA 73: 4225-4229.
18. Gaoni Y, Mechoulam R, (1964). Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 86: 1646-1647.
19. Gulyas AI, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F, et al,. (2004). Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci 20: 441-458. (Pubitemid 38969629)
20. Hashimotodani Y, Ohno-Shosaku T, Kano M, (2007). Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus. J Neurosci 27: 1211-1219. (Pubitemid 46203330)
21. Ho L, Pieroni C, Winger D, Purohit DP, Aisen PS, Pasinetti GM, (1999). Regional distribution of cyclooxygenase-2 in the hippocampal formation in Alzheimer's disease. J Neurosci Res 57: 295-303. (Pubitemid 29339785)
22. Hu SS, Bradshaw HB, Chen JS, Tan B, Walker JM, (2008). Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity. Br J Pharmacol 153: 1538-1549. (Pubitemid 351481525)
23. Hu S, Arnold A, Hutchens JM, Radicke J, Cravatt BF, Wager-Miller J, et al,. (2010). Architecture of cannabinoid signaling in mouse retina. J Comp Neurol 518: 3848-3866.
24. Jhaveri MD, Richardson D, Chapman V, (2007). Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain. Br J Pharmacol 152: 624-632. (Pubitemid 350034979)
25. Jiang M, Deng L, Chen G, (2004). High Ca(2+)-phosphate transfection efficiency enables single neuron gene analysis. Gene Ther 11: 1303-1311. (Pubitemid 39213995)
26. Kellogg R, Mackie K, Straiker A, (2009). Cannabinoid CB1 receptor-dependent long-term depression in autaptic excitatory neurons. J Neurophysiol 102: 1160-1171.
27. Kim J, Alger BE, (2004). Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci 7: 697-698. (Pubitemid 38859050)
28. Kim J, Isokawa M, Ledent C, Alger BE, (2002). Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J Neurosci 22: 10182-10191. (Pubitemid 35416857)
29. Kozak KR, Rowlinson SW, Marnett LJ, (2000). Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J Biol Chem 275: 33744-33749.
30. Kozak KR, Prusakiewicz JJ, Marnett LJ, (2004). Oxidative metabolism of endocannabinoids by COX-2. Curr Pharm Des 10: 659-667. (Pubitemid 38292392)
31. Kreitzer AC, Regehr WG, (2001). Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells. Neuron 29: 717-727. (Pubitemid 32323944)
32. Levison SW, McCarthy KD, (1991). Characterization and partial purification of AIM: a plasma protein that induces rat cerebral type 2 astroglia from bipotential glial progenitors. J Neurochem 57: 782-794.
33. McAdam BF, Mardini IA, Habib A, Burke A, Lawson JA, Kapoor S, et al,. (2000). Effect of regulated expression of human cyclooxygenase isoforms on eicosanoid and isoeicosanoid production in inflammation. J Clin Invest 105: 1473-1482. (Pubitemid 30322413)
34. Maccarrone M, Cecconi S, Rossi G, Battista N, Pauselli R, Finazzi-Agro A, (2003). Anandamide activity and degradation are regulated by early postnatal aging and follicle-stimulating hormone in mouse Sertoli cells. Endocrinology 144: 20-28. (Pubitemid 36076089)
35. Maejima T, Hashimoto K, Yoshida T, Aiba A, Kano M, (2001). Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 31: 463-475. (Pubitemid 32778564)
36. Marrs WR, Blankman JL, Horne EA, Thomazeau A, Lin YH, Coy J, et al,. (2010). The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat Neurosci 13: 951-957.
37. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, et al,. (2002). The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530-534. (Pubitemid 34851398)
38. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI, (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564.
39. Melis M, Pistis M, Perra S, Muntoni AL, Pillolla G, Gessa GL, (2004). Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors. J Neurosci 24: 53-62. (Pubitemid 38181669)
40. Munro S, Thomas KL, Abu-Shaar M, (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65. (Pubitemid 23305569)
41. Patrignani P, Tacconelli S, Sciulli MG, Capone ML, (2005). New insights into COX-2 biology and inhibition. Brain Res Brain Res Rev 48: 352-359. (Pubitemid 40585766)
42. Planas AM, Soriano MA, Rodriguez-Farre E, Ferrer I, (1995). Induction of cyclooxygenase-2 mRNA and protein following transient focal ischemia in the rat brain. Neurosci Lett 200: 187-190.
43. Robbe D, Kopf M, Remaury A, Bockaert J, Manzoni OJ, (2002). Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens. Proc Natl Acad Sci USA 99: 8384-8388. (Pubitemid 34651061)
44. Sang N, Zhang J, Chen C, (2006). PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons. J Physiol 572 (Pt 3): 735-745.
45. Schlosburg JE, Blankman JL, Long J, Nomura DK, Pan B, Kinsey SG, et al,. (2010). Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci 13: 1113-1119.
46. Slanina KA, Schweitzer P, (2005). Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus. Neuropharmacology 49: 653-659. (Pubitemid 41208287)
47. Stella N, Schweitzer P, Piomelli D, (1997). A second endogenous cannabinoid that modulates long-term potentiation. Nature 388: 773-778. (Pubitemid 27375156)
48. Straiker A, Mackie K, (2005). Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. J Physiol 569: 501-517. (Pubitemid 41830118)
49. Straiker A, Mackie K, (2009). Cannabinoid signaling in inhibitory autaptic hippocampal neurons. Neuroscience 163: 11.
50. Straiker A, Hu SS, Long JZ, Arnold A, Wager-Miller J, Cravatt BF, et al,. (2009). Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons. Mol Pharmacol 76: 1220-1227.
51. Teismann P, Tieu K, Choi DK, Wu DC, Naini A, Hunot S, et al,. (2003). Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration. Proc Natl Acad Sci USA 100: 5473-5478. (Pubitemid 36542729)
52. Telleria-Diaz A, Schmidt M, Kreusch S, Neubert AK, Schache F, Vazquez E, et al,. (2010). Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: involvement of prostaglandins and endocannabinoids. Pain 148: 26-35.
53. Tocco G, Freire-Moar J, Schreiber SS, Sakhi SH, Aisen PS, Pasinetti GM, (1997). Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease. Exp Neurol 144: 339-349. (Pubitemid 27224561)
54. Trettel J, Levine ES, (2003). Endocannabinoids mediate rapid retrograde signaling at interneuron right-arrow pyramidal neuron synapses of the neocortex. J Neurophysiol 89: 2334-2338. (Pubitemid 36444285)
55. Tsou K, Nogueron MI, Muthian S, Sanudo-Pena MC, Hillard CJ, Deutsch DG, et al,. (1998). Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neurosci Lett 254: 137-140. (Pubitemid 28459400)
56. Vardeh D, Wang D, Costigan M, Lazarus M, Saper CB, Woolf CJ, et al,. (2009). COX-2 in CNS neural cells mediates mechanical inflammatory pain hypersensitivity in mice. J Clin Invest 119: 287-294.
57. Waleh NS, Cravatt BF, Apte-Deshpande A, Terao A, Kilduff TS, (2002). Transcriptional regulation of the mouse fatty acid amide hydrolase gene. Gene 291: 203-210. (Pubitemid 34722390)
58. Wilson RI, Nicoll RA, (2001). Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410: 588-592. (Pubitemid 32267203)
59. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF, (1993). Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 11: 371-386. (Pubitemid 23250354)
60. Yanovsky Y, Mades S, Misgeld U, (2003). Retrograde signaling changes the venue of postsynaptic inhibition in rat substantia nigra. Neuroscience 122: 317-328. (Pubitemid 37410163)